Name
HansaBioMed Life Sciences OÜ
Registry code
12993514
VAT number
EE101867663
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
10.02.2016 (9)
Financial year
01.01-31.12
Capital
102 516.00 €
Activity
47991 - Other retail sale not in stores, stalls or markets 72111 - Research and experimental development on biotechnology
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Antonio Chiesi
| - | Board member | - | |
| Paolo Guazzi
| - | Board member | - | |
| BioBalt Holding OÜ 11393103 | - | - | - | Founder |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 251 691.89 € | 33 974.22 € | 35 970.69 € | 9 |
| 2024 Q3 | 209 699.21 € | 46 012.24 € | 48 749.12 € | 9 |
| 2024 Q2 | 181 038.19 € | 32 050.16 € | 33 941.99 € | 10 |
| 2024 Q1 | 160 852.1 € | 32 034.76 € | 33 730.29 € | 9 |
| 2023 Q4 | 271 145.83 € | 31 513.66 € | 33 401 € | 9 |
| 2023 Q3 | 203 990.91 € | 34 026.72 € | 36 099.56 € | 9 |
| 2023 Q2 | 211 040.82 € | 33 800.5 € | 36 021.07 € | 10 |
| 2023 Q1 | 226 879.79 € | 32 427.31 € | 34 236.35 € | 10 |
| 2022 Q4 | 175 321.1 € | 34 649.88 € | 36 822.79 € | 11 |
| 2022 Q3 | 130 119.7 € | 35 174.43 € | 37 178.23 € | 11 |
| 2022 Q2 | 142 953.19 € | 35 528.94 € | 37 810.01 € | 11 |
| 2022 Q1 | 174 890.49 € | 35 761.43 € | 37 827.73 € | 12 |
| 2021 Q4 | 149 772.45 € | 35 842.36 € | 38 100.43 € | 13 |
| 2021 Q3 | 161 958.7 € | 36 843.02 € | 39 146.07 € | 13 |
| 2021 Q2 | 116 871.33 € | 34 351.12 € | 36 707.79 € | 13 |
| 2021 Q1 | 142 020.08 € | 33 368.08 € | 35 695.32 € | 12 |
| 2020 Q4 | 139 311.02 € | 30 296.08 € | 32 363.82 € | 11 |
| 2020 Q3 | 100 946.53 € | 25 510.46 € | 27 229.5 € | 10 |
| 2020 Q2 | 73 518.88 € | 23 547.89 € | 25 150.56 € | 10 |
| 2020 Q1 | 168 530.81 € | 28 762.82 € | 29 566.33 € | 10 |
